CAPRICOR THERAPEUTICS, INC. — Form 8-K
Filed July 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
The 8-K filing header indicates an entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation (Item 2.03), filed July 14, 2026 for period ending July 9, 2026. However, the actual agreement text, counterparty name, dollar amounts, terms, and specific obligations are not present in the submitted filing text—only metadata and XBRL file references are shown.
Why this rating
Cannot assess significance without actual agreement details. Header signals material event, but no concrete facts provided to evaluate relative to $399M market cap.
Extracted items
- 1.01 material agreement
- 2.03 material obligation
See more from July 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.